Fewer drugs become eligible for Medicare drug price negotiation under the orphan drug exclusion
Potential Impact — May lead to higher Medicare and patient out-of-pocket costs that reduce visits or treatment options.
Potential Impact — May lead to higher Medicare and patient out-of-pocket costs that reduce visits or treatment options.
Potential Impact —Reduced visits or an increase in uncompensated care as people lose access to coverage.
Potential Impact — An end to short-term relief from ongoing reimbursement challenges.
Temporary 2.5% payment increase under the Medicare PFS ends Read More »
Potential Impact — May lead to automatic cuts to Medicare of roughly $500 billion from 2026 to 2034 and $45 billion in 2026 alone and lead to reduced reimbursements to providers.
Potential Impact — Some short-term relief from ongoing reimbursement challenges.
Medicare Savings Program (MSP) eligibility and enrollment, making it easier for Medicare recipients to enroll in MSPs Medicaid, CHIP, and the Basic Health Program prohibition, making enrollment easier for Medicare recipients Potential Impact — Possible decrease in Medicare recipients in MSPs, Medicaid, Chip and the Basic Health Program.
In Effect Prior to September 2025: End to enforcement of CMS rule on: Read More »